12 month contract focused on the development of new antiviral drugs Novel candidates to be produced using Kimer Med's broad-spectrum antiviral platform 95% of viral diseases lack an approved antiviral treatment Download high resolution ...
MINNEAPOLIS , March 4, 2024 /PRNewswire/ -- Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according ...
- CBL-514 is the first and only drug to receive both Orphan Drug Designation and Fast Track designation for Dercum's disease treatment. NEW TAIPEI CITY , March 3, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) ...
BEIJING , SHANGHAI and BOSTON , March 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received IND (Investigational New Drug) approval of its ...
ROCKVILLE, Md. and SUZHOU, China , Feb. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Represents first ever live biotherapeutic product to receive IND clearance for PSC Phase 2 clinical trial will evaluate the safety and efficacy, including clinical endpoints of LB-P8 SEONGNAM, South Korea , Feb. 29, 2024 /PRNewswire/ ...
The federal government promised a Rare Disease Drug Strategy five years ago and announced $1.4 billion in drug funding last March. Today not a single patient has received a single penny from that fund , despite urgent unmet needs The ...
ANDERNACH, Germany , Feb. 28, 2024 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, announced today that its customer Coherus BioSciences, Inc ("Coherus") has launched its UDENYCA® on-body ...
Germany’s De-Scheduling of Cannabis Opens Path to New Opportunities for Tilray in Potential $3bn Medical Market European Union Medical Cannabis Market Now Projected to Become $45bn NEW YORK and NEUMÜNSTER, Germany, Feb. 28, 2024 ...
Launches Natural Natural™ ingredient brand to raise consumer awareness of naturally-derived rare cannabinoids PORTLAND, Ore. , Feb. 27, 2024 /PRNewswire/ -- Cannabis genetics company Phylos ® , along with People Science , a ...
The immunotherapy-boosting drug N-803, with the brand name Anktiva, was granted approval by the U.S. Food and Drug Administration (FDA) on April 22, 2024, based on the positive outcome of a clinical trial ...
Biopharmaceutical companies are once again competing in the development of innovative drugs for metabolic dysfunction-associated steatohepatitis (MASH), after a series of failures faced by drug manufacturers. The US FDA approval of ...
A study was presented by the Gardy Health system in Atlanta, Georgia, US, at the 73rd Annual Scientific Session of the American College of Cardiology. The study was conducted to evaluate the frequency of heart failure hospitalizations (HFH) in ...
Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...
Melanoma is an extremely fatal form of skin cancer and has inherent resistance to both radiotherapy and chemotherapy ( ). The occurrence of Melanoma has been increasing steadily and become a major health issue since the 5-year ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers